Elevated levels of CCL5 in tissues or plasma predicts poor outcomes in breast cancer [36,37], cervical cancer [37], prostate cancer, ovarian cancer [38], gastric cancer [39,40], and pancreatic cancer. Here, CCL5 is linked to breast cancer.